X-Message-Number: 8317
Date: Fri, 13 Jun 1997 20:48:53 -0400
From: Paul Wakfer <>
Subject: Re: review of suspended animation prospects (Msg #8314)

Subtitle: Cryovita Laboratories is Dissolved.

I have a correction to Brian's message concerning the development of
suspended animation via hypothermia. While I did not think it fruitful
to post this correction to sci.cryonics, I believe that here, on
CryoNet, the historical record should be kept accurate. While making the
correction and in order to put it into a context where it could be
understood (and because there always seems to be so much confusion above
which companies in Rancho Cucamonga are doing what), I thought that it
might be beneficial to give more historical detail. I have tried my best
to do this in as objective and value free manner as possible.

Brian wrote:

>This record [for canine bloodless perfusion] was subsequently extended at 21st 
Century >Medicine to about 5 hours.  The motive of this work was exactly what 
you suggest:
>Improving the reversibility of the early stages of human cryopreservation. 

In actuality, the survival record of 5 hours 20 minutes of bloodless
perfusion was achieved by Cryovita Laboratories, when I was President
and Mike Darwin was Research Director. This research occured before 21st
Century Medicine existed and its success was partly responsible for the
formation of 21CM. The work was funded mainly by myself, with the
addition of some money which remained in Cryovita's research fund when I
took over its leadership, and with much equipment purchased by Mike
Darwin from money which he obtained from a key man insurance policy on
Jerry Leaf (this equipment is now owned by BioPreservation, Inc.).

21CM was formed to continue the above 0'C, medically oriented, research
with the purpose of relating cryonics-oriented research to more
mainstream medical goals and researchers. Cryovita Laboratories was to
concentrate on the below 0'C (cryopreservation) research, something that
had been the goal and desire of Jerry Leaf. Part of this restructuring
decision was the exchange, by Cryovita, of its above 0'C research
intellectual assets for a large shareholder position (and a large
receivable for contract research completed) from 21CM. These decisions
were made and implemented in the spring of 1993 well before the
formation of CryoCare Foundation, CryoSpan, Inc. and the incorporation
of BioPreservation, Inc.

When the new facility in Rancho Cucamonga was purchased by the newly
founded 21CM (again made possible both logisticly and monetarily by
myself), Mike Darwin also became research director of 21CM, and Cryovita
Laboratories became a tenant of the facility. Immediately thereafter,
CryoCare Foundation was founded, and BioPreservation and CryoSpan were
incorporated to be cryopreservation and long-term care service
providers, respectively, for CryoCare, and also became tenants of 21CM.
During the first year of 21CM's existence, after funding from its poorly
received prospectus ran out, I continued to fund its existance and
research (on a loan basis, since I was severely eroding my meager
assets). Finally, toward the end of the summer of 1994, Saul Kent and
Bill Faloon of the Life Extension Foundation (having survived the worst
of their crises brought on by the FDA assault on the Foundation), were
able to begin funding the existence and research work of 21CM. As the
FDA threat to LEF has dissipated (completely, as of February 1996) and
as LEF has enlarged their business, Saul and Bill have been able to more
strongly fund 21CM. Personally, I was fortunate that my "loans" were not
lost, but were honored and became a promissory note at a reasonable
interest rate with a monthly payment.

Since the above restructing decision in the spring of 1993, for various
reasons, Cryovita has not been able to carry out its mandate for
cryopreservation research. Instead, some research relating to assessing
the damage done by (then) current human cryopreservation methods was
done by BioPreservation and 21CM. (It has always been confusing, even to
those involved, what company was doing this work since it was lead by
Mike Darwin who was both owner of BioPreservation - which owned much of
the equipment used - and was research director of 21CM, since it also
used equipment owned by Cryovita Laboratories and by 21CM - and even
sometimes by CryoSpan, and since it was funded by both BPI and by 21CM,
all this in a totally mixed up impossible to account for manner).
Finally last year, it was decided to expand 21CM and build a second
research team (headed by Brian Wowk after August 1997) to concentrate on
research aimed at reducing the damage done during human
cryopreservations. At the same time it was decided to exchange all of
Cryovita's remaining assets for shares in 21CM and to dissolve Cryovita.
This dissolution has now been completed and all former shareholders of
Cryovita Laboratories have become shareholders of 21CM (at a rate of six
21CM shares for each Cryovita share).

	Personally, I am saddened at the demise of Jerry Leaf's company
Cryovita Laboratories, which he began in 1978 and was, for so many
years, at the forefront of leading-edge cryonics technology. There is no
question but that I feel a sense of failure at not being able to renew
Cryovita as the vehicle for advance human cryopreservation research
leading to long-term suspended animation. In my view, that "saving
grace" of this failure is the growth and exciting research potential of
21CM, and the beginning and continuation of the revolutionary purposes
of the Prometheus Project. When and if Jerry Leaf is restored to life
some 100 plus years from now, I hope that he will not be dissatisfied
that his efforts with Cryovita Laboratories were clearly one of the
effective causes of the implementation of long-term perfected suspended
animation as an elective medical option in the year 2020.

-- Paul --

Paul Wakfer
email: Voice/Fax:909-481-9620 Page:800-805-2870


Check out the Prometheus Project web site at URL:

Rate This Message: http://www.cryonet.org/cgi-bin/rate.cgi?msg=8317